Ivy Lee
Overview
Explore the profile of Ivy Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez Alvarez A, Patel S, Cieri I, Ghandour S, Boya M, Suarez S, et al.
Sci Prog
. 2025 Mar;
108(1):368504251324332.
PMID: 40033939
Objective: To evaluate and compare the impact of single- versus dual-antiplatelet (SAPT vs DAPT) therapy on coagulation profiles and postoperative outcomes in patients with peripheral arterial disease (PAD). Methods: Patients...
2.
3.
Suarez Ferreira S, Agrawal A, Lee I, Rodriguez A, Cieri I, Young E, et al.
Ann Vasc Surg
. 2024 Jul;
109:273-283.
PMID: 39069123
Background: Graft/stent thrombosis is the leading cause of amputation in patients over 60, and while dual antiplatelet therapy is the standard of care, there is a significant variability in platelet...
4.
Lee I, Agrawal A, Ghandour S, Suarez S, Patel S, Young E, et al.
Ann Vasc Surg
. 2024 Jul;
110(Pt B):246-259.
PMID: 39067844
Background: Elevated glycated hemoglobin (HbA1c) is associated with vascular complications, including arterial thrombosis postrevascularization. However, the objective relationship between levels of HbA1c and coagulation profiles has not been established. This...
5.
Lee I, Aninos A, Lester J, Rotemberg V, Schlessinger D, Weed J, et al.
J Am Acad Dermatol
. 2024 May;
91(2):312-314.
PMID: 38691074
No abstract available.
6.
Gui H, Rezaei S, Schlessinger D, Weed J, Lester J, Wongvibulsin S, et al.
J Invest Dermatol
. 2024 Apr;
144(10):2298-2301.
PMID: 38582369
No abstract available.
7.
Hall R, Suarez S, Majumdar M, Lee I, Zacharias N, Gee D, et al.
Ann Vasc Surg
. 2024 Mar;
104:227-236.
PMID: 38490537
Background: Metabolic comorbidities such as diabetes and obesity are considered pro-inflammatory states which theoretically increase the risk of perioperative thrombotic events across many surgical disciplines. Currently, there is a paucity...
8.
Lee I, Suarez S, Hall R, Majumdar M, Bellomo T, Jessula S, et al.
Vascular
. 2024 Mar;
33(1):3-18.
PMID: 38441042
Background: Antiplatelet therapy is used to prevent thrombosis in patients with peripheral artery disease (PAD) following revascularization. However, the current standard of care for these patients remains at the physician's...
9.
Suarez Ferreira S, Hall R, Morrow K, Patel S, Lee I, Hagos F, et al.
Am J Hematol
. 2024 Feb;
99 Suppl 1:S6-S12.
PMID: 38400527
Women with peripheral artery disease (PAD) have poorer limb salvage outcomes in spite of having lower risk factors for vascular disease than their male counterparts. Mono antiplatelet therapy with aspirin...
10.
Kankaria A, Majumdar M, Lee S, Hall R, Suarez Ferreira S, Lee I, et al.
J Vasc Surg
. 2023 Dec;
80(1):269-278.
PMID: 38122860
Objective: This systematic review aims to comprehensively assess the contemporary literature on platelet function testing (PFT) in individuals undergoing revascularization therapy for peripheral arterial disease (PAD). The goal is to...